Randomized phase II study of clinical effects of ghrelin the perioperative period of esophagectomy with gastric tube reconstruction.
Phase 2
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000007077
- Lead Sponsor
- Department of Gastroenterological Surgery, Department of Surgery, Graduate School of Medicine, Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
with severe co morbid conditions, infectious diseases and a past history of drug allergy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of SIRS Complications
- Secondary Outcome Measures
Name Time Method itrogen balance,Body weight,Body composition, Blood test
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ghrelin's effects on post-esophagectomy recovery in gastric tube reconstruction?
How does ghrelin administration compare to standard-of-care perioperative management in reducing esophagectomy complications?
Which biomarkers correlate with ghrelin efficacy in improving nutritional status after esophagectomy for esophageal cancer?
What adverse events are associated with ghrelin use during the perioperative period of esophageal cancer surgery?
Are there combination therapies involving ghrelin and PPAR agonists for enhancing gastric tube reconstruction outcomes in esophagectomy?